证券代码：920160 证券简称：北矿检测 公告编号：2026-004 北矿检测技术股份有限公司 关于变更签字注册会计师的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 北矿检测技术股份有限公司（以下简称"公司"）于 2025 年 7 月 3 日召开第 一届董事会第二十六次会议、于 2025 年 8 月 1 日召开 2025 年第三次临时股东大 会审议通过了《关于公司拟续聘会计师事务所的议案》，同意续聘天健会计师事 务所（特殊普通合伙）为公司 2025 年年度审计机构。详见公司于 2025 年 7 月 7 日在全国中小企业股份转让系统（https://www.neeq.com.cn）披露的《北矿检测 技术股份有限公司续聘 2025 年度会计师事务所公告》（公告编号：2025-050）。 1.基本信息 李秦先生，2022 年成为注册会计师，2020 年开始从事审计业务，自 2024 年持续在天健会计师事务所（特殊普通合伙）执业，有逾 5 年审计及证券服务执 业经验，具备相应专业胜任能力。 2.诚信情 ...

Group 1: Fixed Income/Banking - Current oil prices are experiencing a pulse-like increase, with historical patterns showing similarities to the early 2022 Ukraine-Russia conflict, but the current price fluctuations may occur at a faster pace due to market conditions [3][11] - Supply-driven oil price increases are generally not expected to trigger monetary policy tightening, as historical experiences indicate that central banks focus on demand-side adjustments [10][11] - The bond market may experience fluctuations in March, influenced by oil prices affecting market sentiment, but long-term bond risks are considered low due to limited holdings [3][11] Group 2: Overseas/Education Research - The ongoing conflict in the Middle East is a major concern for global markets, with escalating oil prices and declining stock markets indicating investor anxiety [12][15] - The approval of a new commercial nuclear reactor in the U.S. marks a significant milestone for the nuclear energy sector, reflecting renewed policy support for advanced nuclear projects [13] - The commercial aerospace sector is expected to see revenue growth driven by government contracts and commercial agreements, despite high capital expenditures and operational losses [14][15] Group 3: Machinery/Construction - The 2026 National People's Congress emphasizes the importance of effective investment, with a focus on major infrastructure projects and the "Six Networks" initiative, which includes water and electricity networks [16][19] - The fiscal policy remains proactive, with record-high government spending and special bond issuance aimed at supporting infrastructure investments [17][19] - The construction sector is expected to benefit from stable infrastructure demand, particularly in energy security and clean energy projects [19] Group 4: Pharmaceuticals - Hutchison China MediTech reported a total revenue of $549 million for 2025, a decrease of 12.96%, while net profit surged by 1111.03% to $457 million [21][22] - The company’s oncology/immunology business generated $286 million, with significant growth in international sales, particularly for its drug, fruquintinib [22][23] - The ATTC platform is progressing into clinical validation, with multiple candidates entering trials, indicating a robust pipeline for future growth [23][24] Group 5: Home Appliances - Bosideng is expected to achieve steady revenue growth, with a projected mid-single-digit increase for the fiscal year, despite a warm winter affecting sales [26][27] - The main brand, down jackets, is anticipated to maintain growth, supported by high-profile designer collaborations [26][27] - The company is focusing on improving operational efficiency and management capabilities across its various business segments [27][28] Group 6: North Exchange - North Mining Testing is positioned as a leader in the non-ferrous metal testing sector, benefiting from rising metal prices and the domestic demand for quality control [30][31] - The testing services market is projected to reach ¥487.6 billion by 2024, with a significant shift towards larger, more concentrated firms [30][31] - The company is expanding its business model to include high-end instrument development, enhancing its competitive edge in the market [31][32]

Investment Rating - The report assigns a "Buy" rating for the company, indicating a positive outlook based on its authoritative position in non-ferrous metal testing and growth drivers from metal price increases and domestic instrument development [5][9]. Core Insights - The company is a leader in the non-ferrous metal mineral product testing sector, holding the highest market share in 2023. Its business model focuses on entrusted testing and high-margin arbitration testing, supported by self-developed online analysis instruments, creating a dual-driven growth model of "testing services + instrument business" [6][9]. - The overall market for testing services in China is projected to reach CNY 4,876 billion by 2024, with the mining and metallurgy testing sector expected to grow to CNY 56.15 billion, indicating a significant structural upgrade and concentration trend within the industry [8][11]. - The company anticipates steady revenue growth driven by rising metal prices and expanding industry demand, with projected revenues of CNY 1.51 billion, CNY 1.80 billion, and CNY 2.12 billion for 2025-2027 [10][11]. Summary by Sections Industry Overview - The testing industry is recognized as a strategic emerging industry in China, with government policies promoting its development. The market size is expected to grow significantly, with a compound annual growth rate of approximately 11.34% from 2016 to 2024 [16][19]. - The mining and metallurgy testing sector is experiencing a concentration trend, with the number of institutions decreasing while the market size increases, indicating a shift towards larger, more capable firms [37][41]. Company Positioning - The company has established a high barrier to entry in the non-ferrous metal testing market through its deep technical expertise and authoritative qualifications. It is recognized as a designated institution by the London Metal Exchange (LME) [8][11]. - The company’s core revenue sources include ore and concentrate testing, which accounts for approximately 80% of its income, and it is actively expanding into high-growth areas such as self-developed instruments and lithium carbonate futures testing [8][11]. Financial Projections - The company forecasts net profits of CNY 0.74 billion, CNY 0.89 billion, and CNY 1.07 billion for 2025-2027, with corresponding price-to-earnings ratios of 38, 32, and 26 times [6][9]. - Revenue for the first half of 2025 reached CNY 85.94 million, reflecting a year-on-year growth of 31.3%, indicating strong operational performance [8][11].

证券代码：920160 证券简称：北矿检测 公告编号：2026-003 并换发营业执照的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、基本情况 北矿检测技术股份有限公司（以下简称"公司"）于 2025 年 12 月 9 日召开 第一届董事会第三十一次会议、于 2025 年 12 月 26 日召开 2025 年第四次临时股 东会，审议通过《关于变更注册资本、公司类型、经营范围、调整董事会人数并 修订<公司章程>及相关议事规则的议案》。具体内容详见公司在北京证券交易 所信息披露平台（https://www.bse.cn/）上披露的《关于拟变更注册资本、公司类 型、经营范围、调整董事会人数并修订<公司章程>的公告》（公告编号：2025-134）。 二、工商变更登记情况 变更后的《营业执照》记载信息如下： 北矿检测技术股份有限公司 关于完成工商变更登记及公司章程备案 2026 年 2 月 11 日，公司已完成相应的工商变更登记及公司章程备案手续， 并取得北京市大兴区市场监督管理局核发的《营业执照》。 ...

Financial Performance - The company reported a revenue of ¥187,389,493.62 for the reporting period, representing a year-on-year increase of 26.60%[3] - The total profit amounted to ¥87,427,317.59, reflecting a growth of 38.92% compared to the previous year[3] - Net profit attributable to shareholders reached ¥73,928,798.65, up by 34.09% year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥72,315,598.81, showing a significant increase of 42.83%[3] - Basic earnings per share were reported at ¥0.85, which is a 30.77% increase from the previous year[3] Assets and Equity - Total assets at the end of the reporting period were ¥606,480,625.56, marking a 74.93% increase from the beginning of the period[4] - Shareholders' equity attributable to the company was ¥529,927,570.36, up 75.11% from the start of the period[4] Business Growth and Strategy - The growth in revenue and a decrease in operating expenses contributed to the increase in net profit[5] - The company expanded its business scope and achieved diversification, leading to sustained growth in both testing and instrumentation sectors[5] Cautionary Notes - The financial data presented is preliminary and has not been audited, cautioning investors to be aware of potential risks[6]

Core Insights - The professional services sector experienced a slight increase of 0.01% on January 16, with Electric Science Institute leading the gains [1] - The Shanghai Composite Index closed at 4101.91, down 0.26%, while the Shenzhen Component Index closed at 14281.08, down 0.18% [1] Performance Summary - Electric Science Institute (300215) saw a closing price of 8.16, with a significant increase of 20.00% and a trading volume of 809,400 shares [1] - West High Institute (688334) closed at 25.06, up 19.50%, with a trading volume of 313,600 shares [1] - National Achievement Testing (301289) closed at 63.55, up 5.04%, with a trading volume of 33,200 shares [1] - Other notable performers include Victory Nano (688757) with a 4.12% increase, and Broadcasting Measurement (002967) with a 4.01% increase [1] Capital Flow Analysis - The professional services sector saw a net inflow of 58.26 million yuan from institutional investors, while retail investors experienced a net outflow of 33.14 million yuan [2] - Electric Science Institute had a net inflow of 18.9 million yuan from institutional investors, representing 30.20% of its total trading volume [3] - West High Institute experienced a net inflow of 6.88 million yuan from institutional investors, with a net outflow of 39.03 million yuan from retail investors [3]

证券代码：920160 证券简称：北矿检测 公告编号：2026-001 北矿检测技术股份有限公司 关于使用闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、授权现金管理情况 （一）审议情况 北矿检测技术股份有限公司（以下简称"公司"）于 2025 年 12 月 26 日召开 公司第二届董事会审计委员会第一次会议、第二届董事会独立董事专门会议第一 次会议和第二届董事会第一次会议，审议通过《关于使用闲置募集资金进行现金 管理的议案》，同意公司拟使用额度不超过人民币 1.60 亿元（包含本数）的闲置 募集资金进行现金管理，用于购买安全性高、流动性好、风险低的本金保障型产 品（包括但不限于 7 天通知存款、定期存款、大额存单等），拟投资产品的期限 最长不超过 12 个月，在上述额度内，资金可循环滚动使用，董事会授权总经理 行使相关投资决策权并签署相关文件，公司财务部负责具体组织实施及办理相关 事宜。 具体内容详见公司于 2025 年 12 月 30 日在北京证券交易所信息披 ...

Group 1 - The company, Beikong Testing, announced the approval of several key resolutions during the first meeting of its second board of directors, including the election of the chairman of the board [2] - The company also approved the election of members and conveners for its specialized committees [2] - Additionally, the company appointed a new general manager as part of the resolutions passed [2]

目 录 一、以自筹资金预先投入募投项目及支付发行费用的鉴证报告…第 1—2 页 二、以自筹资金预先投入募投项目及支付发行费用的专项说明…第 3—4 页 北矿检测技术股份有限公司全体股东： 我们鉴证了后附的北矿检测技术股份有限公司（以下简称北矿检测公司）管 理层编制的《以自筹资金预先投入募投项目及支付发行费用的专项说明》。 一、对报告使用者和使用目的的限定 三、资格证书复印件…………………………………………………第 5—8 页 关于北矿检测技术股份有限公司 以自筹资金预先投入募投项目及支付发行费用的 鉴证报告 天健审〔2025〕1-1359 号 本鉴证报告仅供北矿检测公司为以募集资金置换预先投入募投项目及支付 发行费用的自筹资金之目的使用，不得用作任何其他目的。 二、管理层的责任 北矿检测公司管理层的责任是提供真实、合法、完整的相关资料，按照《上 市公司募集资金监管规则》（证监会公告〔2025〕10 号）和《北京证券交易所 上市公司持续监管指引第 9 号——募集资金管理》（北证公告〔2025〕30 号） 的要求编制《以自筹资金预先投入募投项目及支付发行费用的专项说明》，并保 证其内容真实、准确、完整，不存在虚假 ...

中信证券股份有限公司 关于北矿检测技术股份有限公司 使用募集资金置换预先投入募投项目及已支付发行费用的自筹资金 的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐机构"）作为北矿 检测技术股份有限公司（以下简称"公司"、"北矿检测"）向不特定合格投资者 公开发行股票并在北京证券交易所上市的保荐机构，根据《证券发行上市保荐业 务管理办法》《北京证券交易所上市公司持续监管办法（试行）》《北京证券交易 所证券发行上市保荐业务管理细则》《北京证券交易所股票上市规则》《北京证券 交易所上市公司持续监管指引第 9 号——募集资金管理》等有关规定，对北矿 检测使用募集资金置换预先投入募投项目及已支付发行费用的自筹资金事项进 行了核查，并发表意见如下： 一、募集资金基本情况 | 序号 | 项目名称 | 投资总额 | 原募集资金 拟投入金额 | 调整后募集资金 拟投入金额 | | --- | --- | --- | --- | --- | | 1 | 北矿检测先进检测仪 器研发基地及检测能 | 14,257.97 | 14,257.97 | 14,257.97 | | | 力建设项目 | | | | | 2 | 补 ...